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Background: We hypothesized that operative variables might predict survival following liver
transplantation.
Methods: We examined perioperative variables from 469 liver transplants carried out at the University of
Washington during 2003–2006. Logistic regression determined the variables' contributions to survival at
30, 90 and 365 days.
Results: Portal vein blood flow (>1 l/min) was significant to patient survival at 30, 90 and 365 days.
Complete reperfusion was only a significant predictor of survival at 30 days. This provided model receiver
operating characteristic (ROC) area under the curve (AUC) statistics of 0.93 and 0.87 for 30 and 90 days,
respectively. At 365 days, hepatic artery blood flow (>250 ml/min) combined with portal vein blood flow
was significantly predictive of survival, with an AUC of 0.74. A subset analysis of 110 transplants
demonstrated improved 1-year survival with more aggressive vascular revisions.
Discussion: Portal vein blood flow is a significant predictor of survival after liver transplantation. Initially,
the liver's survival is based on portal vein blood flow; however, subsequent biliary problems and patient
demise result from both poor portal vein and inadequate hepatic artery blood flow.
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Introduction
Liver transplantation is the only successful treatment for patients
with end-stage liver disease, but, unfortunately, is predicated on
the availability of donor organs. Because of the relative shortage of
these organs, the success of each transplant is vital to maximize
the benefit from this limited resource. Many studies have exam-
ined the variables predictive of successful liver transplants. Most
studies divide variables into donor and recipient factors.1–3 These
factors can aid transplant surgeons to match donors with recipi-
ents to improve outcomes, but they offer little help in improving
outcomes after the match has been identified. Although operative
variables have not been historically included in prognostic
models, we suspected that, if appropriately discriminatory, they
would represent a unique opportunity for the surgical team to
utilize direct measurements to improve outcomes and identify
patients at risk.
Successful liver transplantation requires establishing the appro-
priate vascular and biliary conduits and their perfusion, along
with optimizing intraoperative cardiovascular parameters and
minimizing blood loss. Although hepatic artery and portal vein
complications are relatively uncommon (occurring in 4–13% and
1–6% of cases, respectively), they are the cause of significant
morbidity and mortality post-liver transplant.4–8 In the late 1980s
stable and reproducible measurements were made of hepatic
blood flow in non-transplant anaesthetized patients.9 It was sub-
sequently shown that there was increased portal vein blood flow in
This paper is based on a presentation given at the American Hepato-
Pancreato-Biliary Association Annual Meeting, 27–30 March 2008, Fort
Lauderdale, Florida.
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individuals receiving a liver transplant and, additionally, an intact
arterial buffer response.10 The association of hepatic arterial blood
flow with stenosis and thrombosis was appreciated and it was then
demonstrated that interventions to improve blood flow could
result in improved outcomes.11–13 More recently, it has been sug-
gested that the portal vein blood flow is the more significant
variable in terms of transplant outcome.14
We were specifically interested in identifying factors that we
could improve after the donor and recipient had been identified
and the procedure initiated. We suspected that beyond impacting
the allograft survival, the vascular inflow would impact patient
survival. We therefore hypothesized that operative variables
might predict allograft and patient survival following liver
transplantation.
Materials and methods
Study period 2003–2006
After institutional review board approval, a retrospective review of
all patients receiving liver transplants in our programme during
2003–2006 was performed. All patients were followed for1 year.
Recipient factors recorded included: age; gender; body mass index
(BMI); laboratory Model for End-stage Liver Disease (MELD)
scores (as calculated and not assigned); whether status 1 at trans-
plantation; race, and aetiology of liver disease classified as autoim-
mune, cryptogenic, ethanol-related, hepatitis B and/or C, primary
biliary cirrhosis, primary sclerosing cholangitis or other. Hepato-
cellular carcinoma with any other diagnosis was also noted.Donor
factors of age, gender, BMI, cold ischaemia time (the length of
time the donor organ is flushed with cold solution until it is
removed from ice just prior to anastomosis in the recipient), type
of donor (identified by donation after either cardiac [DCD] or
brain [DBD] death), cause of death and race were recorded. No
preoperative vascular imaging of the recipient was performed on
a routine basis. Patient and graft survival were determined for 1
year following transplantation.
The surgical technique used for both DBD and DCD hepatic
allografts was the rapid flush procedure for donor hepatectomies
as described by Starzl et al.15 Allograft preservation with Univer-
sity of Wisconsin solution was used exclusively except in DCD
procedures, which utilized histidine-tryptophan-ketoglutarate
(HTK) solution for preservation in some.
Anaesthesia was administered via general endotracheal intuba-
tion with rapid sequence induction and maintenance anaesthetic
was tailored to maintain haemodynamic stability with minimal
cardiac stress. All recipients underwent placement of a Swan–
Ganz catheter for the collection of cardiopulmonary parameters.
Recipient liver implantation was performed in either piggyback
(with or without triangulation) or bi-caval fashion following
partial or complete caval occlusion with or without veno–venous
bypass or portal–caval shunt. The donor organ was flushed with
2–3 l of chilled lactated Ringer’s solution prior to implantation.
The donor portal vein was anastomosed to the recipient in an
end–end fashion whenever possible. Similarly, the donor hepatic
artery or coeliac trunk was anastomosed with an aortic patch to
the recipient hepatic artery, preferably at a patch formed by the
bifurcation of the common hepatic artery into the gastroduodenal
and the proper hepatic arteries. The vena cava was flushed of
approximately 300–500 ml of blood and the portal vein was
flushed of clot prior to reperfusion on a regular, although not
categorical, basis.
Intraoperative factors were recorded at various time-points.
The anastomotic time (time from removing the liver from ice and
completing the inferior vena cava and portal vein anastomoses to
the start of reperfusion) was recorded. Upon recirculation, the
surgical team recorded the characteristics of reperfusion (com-
plete, patchy or segmental) and the speed (fast, slow or none).
Following successful implantation and at a point of haemody-
namic stability, the anaesthesia team collected the cardiac index
and the surgical team documented hepatic artery and portal vein
blood flow via an ultrasonic flow probe. Before completing the
biliary anastomosis, bile production (yes or no) was recorded. At
the end of the procedure following abdominal closure, the esti-
mated blood loss and amount of packed red blood cells transfused
were recorded by the anaesthesia team.
Study period 2007 to August 2008
Subsequent to institutional review board approval, all patients in
this period were followed only for patient and graft survival and
hepatic artery blood flow, portal vein blood flow and the charac-
teristics of reperfusion.Only patients with 90-day follow-ups were
considered. The only surgical difference between data collection in
this period and the prior period is that the surgical team noted the
hepatic artery blood flow and portal vein flow during the proce-
dure. In the presence of inadequate flows, the surgeon conducted
anastomotic revisions, vascular jump grafts, etc. in an attempt to
increase the measured blood flows. The new flows were recorded
after completion of the revisions.
Statistical analysis
Continuous variables were given as the mean  standard devia-
tion and categorical variables were presented as percentages.
Survival curves were calculated by Kaplan–Meier analyses and
compared by the log-rank test. Logistic regression was performed
to determine the contributions of the intraoperative variables on
allograft and patient survival at 30, 90 and 365 days. In forward
and backward progression, multivariable logistic regression was
evaluated on all intraoperative univariables with a significance
value of P 0.1. The intraoperative factors found to be significant
in multivariable logistic regression were adjusted for by donor and
recipient factors. The accuracy of the predictive models was
described using the area under the curve (AUC) from the receiver
operating characteristic (ROC) curve. All results were considered
significant with a P-value < 0.05. All statistics were performed
using jmp Version 7.0 (SAS Institute, Inc., Cary, NC, USA).
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Results
Study period 2003–2006
We performed 469 consecutive liver transplants in 445 individuals
at the University of Washington from February 2003 through
December 2006. All patients were followed until 31 December
2007. The demographic and clinical characteristics of our popu-
lation are displayed in Table 1. The recipients included a greater
proportion of men than women (30% female), were predomi-
nantly White, and had a mean age of 53.4  9.2 years. The most
common primary diagnoses were hepatitis C (51.9%), alcoholic
liver disease (25.8%) and primary biliary or sclerosing cholangitis
(6.3% and 5.3%, respectively). The average recipient MELD score
based on a calculated MELD without tumour points was 19.4 
8.9. The donor population was similarly predominantly White
and had a mean age of 38.8 16.2 years and a mean BMI of 26.3
 5.6. A total of 74%were standard donors, 11.3% were DCD and
14.7% were expanded criteria donors (advanced donor age,
hypernatremia, pressor requirement, elevated BMI, elevated liver
function tests, positive HCV serology).
Primary allograft survival rates at 30, 90 and 365 days were
94.8%, 91.9% and 86.1%, respectively; survival rates of grafts used
for re-transplants at 30, 90 and 365 days were 91.7%, 87.5% and
79.2%, respectively (Fig. 1A). Similarly, patient survival at 30, 90
and 365 days was 95.7%, 92.6% and 87.3%, respectively (Fig. 1B).
For the 24 individuals who required re-transplants, survival rates
at 30, 90 and 365 days were 91.7%, 87.5% and 79.2%, respectively.
Notably, there was no significant difference in allograft or patient
survival in terms of MELD score, BMI or aetiology of liver disease
(data not shown).
Within the univariable analysis for intraoperative factors, portal
vein blood flow was consistently the most significant variable in
predicting both allograft (P < 0.0003; data not shown) and patient
(P < 0.0001) survival at 30, 90 and 365 days (Table 2). Hepatic
artery blood flow at 30, 90 and 365 days was slightly less significant
(P = 0.0004, P = 0.004 and P = 0.003, respectively) for patient
survival. Hepatic artery blood flow was also significant (P < 0.03)
for allograft survival. Cardiac index was significant throughout
the univariable analysis for all three time-points. Not surprisingly,
the amount of packed red blood cells transfused was more signifi-
cant than estimated blood loss. Interestingly, anastomotic time
was not significant at any time-point (P  0.4). Further, speed of
reperfusion was less relevant than completeness of reperfusion.
Not making bile was also a significant risk at all time-points.
In the unadjusted multivariable analysis, portal vein blood flow
was significant for patient survival at 30, 90 and 365 days
(Table 3). This, combined with red blood cell transfusion and
complete reperfusion provided a model with ROC AUC statistics
>0.77 at 30 and 90 days for patient survival. However, at 365 days,
hepatic artery blood flow combined with portal vein blood flow
was more predictive of survival (AUC = 0.69). Notably, although
cardiac index was significant in the univariable analysis, it did not
contribute to the significance of the multivariable model. This
was re-confirmed by controlling for individuals with a marginal
Table 1 Recipient and donor demographics (mean  standard
deviation and numbers and percentages)
Demographics and clinical factors
Recipients
Number of patients 445
Number of transplants 469
Re-transplants, n 24
Age, years 53.4  9.2
Male : female 309 : 136
Body mass index 28.7  5.1
Laboratory MELD score 19.4  8.9
Transplant at status 1, n (%) 9 (1.9%)
Race
White 83.6%
African-American 2.3%
Asian 9.6%
Hispanic 2.8%
Other 1.7%
Aetiology of liver diseasea, n (%)
Autoimmune hepatitis 14 (3.2%)
Acute liver failure 13 (2.9%)
Cryptogenic cirrhosis 20 (4.5%)
Alcoholic liver disease 115 (25.8%)
Any combination with hepatitis B virus 50 (11.2%)
Any combination with hepatitis C virus 231 (51.9%)
Non-alcoholic steatohepatitis 22 (4.9%)
Primary biliary cirrhosis 28 (6.3%)
Primary sclerosing cholangitis 24 (5.3%)
Any combination with hepatocellular carcinoma 132 (29.7%)
Donors
Age, years 38.8  16.2
Male : female 287 : 182
Body mass index 26.3  5.6
Cold ischaemia time, min 432  166
Type of donor
Donation after cardiac death 11.3%
Extended criteria donorb 14.7%
Standard donor 74.0%
Cause of death
Motor vehicle accident 17.5%
Gun shot to head 11.3%
Closed head injury 11.6%
Cerebrovascular accident/anoxia 55.0%
Other 4.6%
Race
White 84.0%
African-American 3.3%
Asian 5.6%
Hispanic 4.0%
Other 3.1%
aDiagnoses do not total 100% as a result of overlapping diagnoses
bAs determined by the organ procurement organization
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cardiac index (<2); the multivariable analysis demonstrated the
same results (data not shown).
There was no difference in the multivariable analysis in terms of
allograft survival regarding portal vein blood flow as a significant
predictor at 30, 90 and 365 days (data not shown). However, at 30
and 90 days complete reperfusion remained, but red blood cell
transfusion dropped out as a significant predictor. At 30 and 90
days portal vein blood flow and complete reperfusion provided
the more robust multivariable model (AUC > 0.74). At 365 days,
portal vein blood flow alone was significant in predicting allograft
survival echoing patient survival.
Adjusting for donor and recipient factors revealed that portal
vein blood flow continued to be a significant predictor of patient
survival at 30, 90 and 365 days (Table 4). Red blood cell transfu-
sion ceased to be a significant factor for predicting patient survival
at either 30 or 90 days. Although complete reperfusion continued
to be a significant predictor at 30 days, its significance declined to
P = 0.06 at 90 days. Hepatic artery blood flow continued to be a
significant predictor of patient survival at 365 days. Only portal
blood flow remained a significant predictor of graft survival at any
time period in the adjusted analysis (data not shown).
Portal vein blood flow
The distribution of portal vein blood flow in our patients is shown
in Fig. 2.To ascertain themost desirable portal flow for best patient
survival following liver transplantation, the flows were divided
into seven groups according to flow rate/min (150–500 ml/min,
501–1000 ml/min, 1001–1500 ml/min, 1501–2000 ml/min,
2001–2500 ml/min, 2501–3000 ml/min and >3000 ml/min). The
1-year survival curves demonstrate that the groups with flows of
150–500 ml/min and 501–1000 ml/min have significantly worse
survival when independently compared with the other groups
(Fig. 3). This indicates that a portal vein blood flow >1 l/min is
required in liver transplantation to obtain better patient survival.
Hepatic artery blood flow
The distribution of hepatic artery blood flows in our patients is
shown in Fig. 4. To ascertain the most desirable hepatic artery
blood flow for best patient survival following liver transplanta-
tion, the flows were divided into three groups (50–250 ml/min,
251–400 ml/min and >400 ml/min). The survival curves reveal
that the group with flow of 50–250 ml/min had significantly (P =
0.002) poorer survival than the >400 ml/min group (Fig. 5). The
251–400 ml/min group shows a trend (P = 0.1) towards poorer
survival than the >400 ml/min group.
Study period 2007 to August 2008
In the next 18 months we performed 133 liver transplants, of
which 110 had follow-ups 90 days. In these patients there was a
decrease in the percentage of transplants completed with hepatic
artery blood flow <250 ml/min (from 24.3% to 10.0%; P =
0.0007). There was similarly, although not quite as significantly, a
decline in the percentage of transplants completed with portal
vein blood flow of <1 l/min (from 10.2% to 5.4%; P = 0.07). The
incidence of incomplete reperfusion on recirculation is not modi-
fiable and remained the same in both periods, at 4% (P = 0.6).
Interestingly, survival between the period 2003–2006 and the
period in which more aggressive vascular revisions were per-
formed to improve blood flow is significantly improved (Fig. 6).
In the revision period only incomplete perfusion remains signifi-
cant (odds ratio 20; 95% confidence interval 2.6–155; P = 0.01) for
indicating patient and graft failure at 90 days.
Discussion
Portal vein blood flow following reperfusion is a significant pre-
dictor of allograft and patient survival after liver transplantation.
During the initial 90 days after transplantation, the allograft’s and
recipient’s survival is based on portal vein blood flow, regardless
of hepatic artery flow. However, subsequent biliary problems and
allograft and patient demise are likely to reflect a combination
of poor portal vein and inadequate hepatic artery blood flow.
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Figure 1 (A) Graft and (B) patient survival at 1 year after orthotopic
liver transplantation during the initial review of this study (2003–
2006)
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Aggressive vigilance and intervention(s) to maximize these vascu-
lar parameters resulted in significantly improved 90-day mortality
in a second cohort of individuals undergoing liver transplantation.
Portal vein blood flow was consistently significant in predict-
ing allograft and patient survival at 30, 90 and 365 days. By con-
trast, whereas completeness of reperfusion was significant at 30
days, hepatic artery blood flow was more significant at 365 days.
Completeness of reperfusion is clearly a reflection of the initial
allograft viability; incomplete perfusion, in addition to precipi-
tating an intraoperative ultrasound and review of the inflow and
outflow, should increase vigilance for primary non-function. In
the unadjusted analysis, the volume of blood loss was a signifi-
cant predictor of survival. The volume of blood transfused is
probably a surrogate for the difficulty of the dissection and the
amount of physiological stress the recipient is subjected to
during the procedure and is thus likely to be confounded by
several factors. If the individual’s cardiopulmonary fitness toler-
ates the resultant fluid shifts in the acute period, over time the
weight of this variable is significantly reduced. Notably, we regu-
larly flush approximately 300–500 ml of blood from the inferior
vena cava during reperfusion; thus, a realized blood loss of
300–500 ml is a substantially lesser insult than a blood loss of
Table 2 Study population of intraoperative variables comparing patients who survived with those who expired for the different time periods
Factors Survivala Deatha P OR 95% CI
30-day survival
Anastomotic time, min 38.1  9.5 38.5  13.5 0.9 1.005 0.96–1.04
Hepatic artery blood flow, ml/min 419  224 281  204 0.0004 0.01 0.0001–0.19
Portal vein blood flow, l/min 1.9  0.7 1.1  0.8 <0.0001 0.14 0.05–0.32
Cardiac index 5.4  1.8 3.9  1.9 0.003 0.56 0.4–0.76
Estimated blood loss, l 1.9  2.5 3.6  4.4 0.02 1.12 1.009–1.23
Packed red blood cells transfused, l 0.8  0.8 2.4  4.4 0.001 1.9 1.27–3.04
Complete reperfusion, yes vs. no 97% 78% 0.001 0.32 0.2–0.6
Fast reperfusion, yes vs. no 93% 78% 0.03 0.54 0.33–0.96
Not making bile at close, yes vs. no 3% 19% 0.006 2.74 1.4–4.9
90-day survival
Anastomotic time, min 38.2  9.5 36.7  12 0.4 0.98 0.94–1.02
Hepatic artery blood flow, ml/min 419  223 335  234 0.004 0.11 0.01–0.79
Portal vein blood flow, l/min 1.9  0.7 1.2  0.7 <0.0001 0.17 0.08–0.34
Cardiac index 5.4  1.7 4.7  2.5 0.01 0.77 0.61–0.96
Estimated blood loss, l 1.9  2.5 3  3.7 0.03 1.09 1.001–1.2
Packed red blood cells transfused, l 0.8  0.8 1.9  3.6 0.002 1.72 1.2–2.6
Complete reperfusion, yes vs. no 97% 85% 0.01 0.42 0.24–0.77
Fast reperfusion, yes vs. no 92.00% 86% 0.2 0.7 0.44–1.2
Not making bile at close, yes vs. no 3% 12% 0.03 2.1 1.1–3.6
365-day survival
Anastomotic time, min 38.2  9.5 37.4  10.9 0.6 0.99 0.96–1.02
Hepatic artery blood flow, ml/min 422  224 340  212 0.003 0.12 0.02–0.61
Portal vein blood flow, l/min 1.9  0.7 1.4  0.8 <0.0001 0.35 0.2–0.56
Cardiac index 5.4  1.7 4.9  2.3 0.04 0.85 0.7–0.98
Estimated blood loss, l 1.9  2.5 2.8  3.2 0.03 1.09 1.001–1.19
Packed red blood cells transfused, l 0.8  0.8 1.6  3 0.02 1.5 1.12–2.13
Complete reperfusion, yes vs. no 97% 89% 0.01 0.47 0.28–0.82
Fast reperfusion, yes vs. no 93% 85% 0.06 0.67 0.45–1.05
Not making bile at close, yes vs. no 3% 10% 0.04 1.85 1.03–3.11
Differences determined by univariable logistic regression analysis of the intraoperative variables significant for patient survival at 30, 90 and 365 days
following liver transplantation. Values are expressed as mean standard deviation for continuous variables and percentages for categorical variables.
All factors were continuous variables except for complete reperfusion (yes vs. no), fast reperfusion (yes vs. no), and not making bile at termination of
liver transplant (yes vs. no) All results were considered significant with a P-value < 0.05
aAverage values between the two groups (Survival or Death)
OR, odds ratio; CI, confidence interval
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approximately 1600–2400 ml, as evidenced by the results in the
unsuccessful recipients.
The variability in the significance of the hepatic artery blood
flow is probably a reflection of the buffer response relationship of
portal vein and hepatic artery blood flow. More specifically, the
portal vein blood flowmay augment an inadequate arterial recon-
struction or inflow initially, but, ultimately, persistent inadequate
arterial blood flow will compromise the biliary tree. Thus, the liver
is likely to tolerate the perioperative period and the recipient
survives, but ultimately the allograft faces cholangiopathy and
subsequent infectious complications as a result of inadequate
hepatic artery flow.
The baseline for adequate flows would be an ideal target to
obtain when performing a liver transplant. We determined a
target level of blood flow >1 l/min in the portal vein. In the
hepatic artery a baseline flow >250 ml/min is a minimally accept-
able level, but a flow >400 ml/min is ideal. Complete reperfusion
is not modifiable, but it is to be hoped that interventions that
obtain better blood flow are possible.
In termsof potential interventions, the initial action is,of course,
to re-visit the lie of the vessels themselves in the setting of post-
reperfusion. If necessary, the anastomosis is taken down and the
vessels are cut back appropriately and the anastomosis revised.
Papaverinewasusedoften to attempt tobreak arterial vasospasm in
the acute period, and pressors may be necessary to augment the
splanchnic return, depending on the systemic vascular resistance.
However, it should be stressed that our results consistently and
significantly were not impacted by the cardiac parameters. As
discussed in the Results section, a subset analysis extracting the
marginal cardiac indices did not result in significance in the
multivariable analysis. This is consistent with a previous clinical
report that found no significant difference in cardiac output, sys-
temic vascular resistance or blood pressure among individuals
surviving liver transplantation.16 The portal inflowmay require or
benefit from the ligation or clipping of varices and/or shunted
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Figure 2 Distribution of portal vein blood flow (l/min) in 469 liver
transplant patients
Table 3 Unadjusted multivariable analysis of independent intraoperative variables for patient survival
P OR (95% CI) AUC
30-day survival
Portal vein flow, l/min <0.0001 0.31 (0.1–0.84) 0.79, P < 0.0001
Red blood cells transfused, l 0.001 1.53 (1.04–2.61)
Complete reperfusion <0.001 0.32 (0.16–0.68)
90-day survival
Portal vein flow, l/min <0.0001 0.32 (0.14–0.69) 0.77, P < 0.0001
Red blood cells transfused, l 0.002 1.4 (1.04–2.15)
Complete reperfusion 0.01 0.45 (0.23–0.93)
365-day survival
Portal vein flow, l/min <0.0001 0.14 (0.2–0.66) 0.69, P < 0.0001
Hepatic artery flow, ml/min 0.003 0.34 (0.02–0.56)
All variables with a significance of P  0.1 from the univariable analysis were included in the multivariable analysis. Forward and backward regression
analysis of independent variables for combined contribution toward patient survival at 30, 90, and 365 days following liver transplantation produced
the same significant variables. All results were considered significant with a P-value < 0.05. The area under the curve (AUC) in receiver operating curve
(ROC) analysis was similarly considered significant with a P-value < 0.05
OR, odds ratio; CI, confidence interval
Table 4 Adjusted multivariable analysis of independent intraopera-
tive variables for patient survival
P OR (95% CI) AUC
30-day survival
Portal vein flow, l/min 0.05 0.31 (0.11–0.86) 0.93
Red blood cells transfused, l 0.08 1.29 (0.98–1.92)
Complete reperfusion 0.01 0.10 (0.04–0.54)
90-day survival
Portal vein flow, l/min 0.03 0.35 (0.15–0.78) 0.87
Red blood cells transfused, l 0.2 1.26 (0.89–1.97)
Complete reperfusion 0.06 0.62 (0.41–1.01)
365-day survival
Portal vein flow, l/min 0.02 0.54 (0.28–0.92) 0.74
Hepatic artery flow, ml/min 0.04 0.98 (0.97–0.99)
Adjustment for recipient and donor factors. All results were considered
significant with a P-value < 0.05
OR, odds ratio; CI, confidence interval; AUC, area under the curve
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blood flow if the portal flow is being compromised by blood
flowing into a varix. Further, in some instances it is necessary to
perform thrombectomy of the portal inflow and it may also be
appropriate to instigate a venous conduit to augment inflow. Ulti-
mately, it must be recognized that not all interventions will be
beneficial; the flowmeasurementswill remain unimproved and the
patient will require increased vigilance for the possibility of a poor
outcome without re-transplantation. Recognizing this early and
planning appropriatelymaybe thebest‘perioperative intervention’.
There were several limitations inherent in this data collection
and it is important to stress that this is not meant as a celebration
of intraoperative flow measurements. This was a retrospective
review; blood flows before and after any interventions, which were
not defined, were not reported, which unfortunately limits discus-
sion as to what were the best interventions. Portal vein and hepatic
artery blood flow measurements were taken post-reperfusion at
an arbitrary point of gross haemodynamic stability. The timing
was not standardized any further than the attending surgeon’s
appreciation of haemodynamic stability. Individual interventions
to improve or augment blood flows were not differentiated. Ulti-
mately, and this is the most practical point, hepatic artery and
portal vein flows in those who did and did not develop allograft
dysfunction or death overlap; thus, flows alone may be difficult to
use as prognosticators. This clearly illustrates that this is not an
advertisement for transonic flow probes, but a recognition of their
simple intraoperative utility. Their value probably resides in their
contribution to a functional multi-factorial model of prognosti-
cation or, at the very least, to an easily identified and communi-
100
80
60
40
20
0
0 90 180
501–1000 ml/min
150–500 ml/min
P < 0.0001
P < 0.0001
Days
S
ur
vi
va
l, 
%
270 360
Figure 3 One-year patient survival by portal vein blood flow (ml/min)
in seven groups (150–500 ml/min, 501–1000 ml/min, 1001–1500 ml/
min, 1501–2000 ml/min, 2001–2500 ml/min, 2501–3000 ml/min and
>3000 ml/min). Survival rates for both the 150–500 ml/min and
501–1000 ml/min groups are independently significantly different
compared with the rate for the other five groups combined
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Figure 4 Distribution of hepatic artery blood flow (ml/min) in 469 liver
transplant patients
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Figure 6 Orthotopic liver transplantation patient survival during
2003–2007 showing patient survival following transplantation during
the initial study period of 2003–2006 vs. patient survival in the
subsequent follow-up. Patient survival significantly increased as a
result of ‘revisions’ based on the recognition of inadequate portal
vein or hepatic artery blood flow as demonstrated during the initial
study period (P = 0.01)
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cated variable of probable graft and patient outcome. Obviously,
intraoperative Doppler ultrasound, although it is more time- and
labour-intensive, would be a more valuable adjunct in demon-
strating successful liver perfusion in experienced hands.
In summary, portal vein and hepatic artery blood flow are
significant predictors of allograft and patient survival and
represent unique opportunities to directly modify survival
outcome after transplantation. These data suggest that during the
initial 90days following transplantation, the liver’s survival is based
on portal vein blood flow, regardless of hepatic artery flow.
However, subsequentbiliaryproblemsandpatient demise are likely
to reflect a combination of both poor portal vein and inadequate
hepatic artery blood flow. Ultimately, these operative variables
predict allograft and patient survival. Recognition of appropriate
inflow and conduit is among the surgeon’s foremost responsibili-
ties and offers an opportunity to effect a change in outcome.
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